RPRX · Royalty Pharma plc Class A Ordinary Shares
View on chartInsiders & Stakes
| GG 1978 SICAF SIF S.A. | ▼ Sell | Open Market | 22,081,156 Shares held | 9/15/2022 | View profile |
| GG 1978 SICAF SIF S.A. - GG Strategic | ▼ Sell | Open Market | 21,426,170 Shares held | 9/20/2022 | View profile |
| Avara Management Ltd | ▼ Sell | Open Market | 2,477,520 Shares held | 12/29/2023 | View profile |
| Pablo G. Legorreta CEO, Chairman of the Board | ▲ Buy | Grant | 1,307,820 Shares held | 8/5/2026 | View profile |
| Reddoch James F. EVP & Chief Scientific Officer | ▼ Sell | Open Market | 820,800 Shares held | 9/28/2022 | View profile |
| Rory B. Riggs Director | ▼ Sell | Other | 320,099 Shares held | 2/20/2024 | View profile |
| Christopher Hite EVP & Chairman, Partnering | ▼ Sell | Open Market | 270,401 Shares held | 9/22/2026 | View profile |
| Gregory Norden Director | ▲ Buy | Grant | 196,348 Shares held | 6/5/2026 | View profile |
| Errol B. Desouza Director | ▲ Buy | Grant | 81,352 Shares held | 5/13/2025 | View profile |
| Bonnie L. Bassler Director | ▲ Buy | Grant | 79,823 Shares held | 9/30/2026 | View profile |
| Henry A. Fernandez Director | ▲ Buy | Grant | 65,324 Shares held | 6/30/2025 | View profile |
| Ted W. Love Director | ▲ Buy | Grant | 58,393 Shares held | 6/5/2026 | View profile |
| Catherine M. Engelbert Director | ▲ Buy | Grant | 55,673 Shares held | 6/5/2026 | View profile |
| David C. Hodgson Director | ▲ Buy | Grant | 37,873 Shares held | 6/5/2026 | View profile |
| Vlad Coric Director | ▲ Buy | Grant | 15,343 Shares held | 6/5/2026 | View profile |
| Elizabeth H. Weatherman Director | ▲ Buy | Grant | 13,103 Shares held | 6/5/2026 | View profile |
| Giuliani Mario Germano | ▲ Buy | Grant | 7,747 Shares held | 6/23/2023 | View profile |
| Carole Ho Chief Medical Officer | ▲ Buy | Grant | 4,545 Shares held | 6/5/2026 | View profile |
| Terrance P. Coyne EVP & CFO | ▼ Sell | Open Market | 0 Shares held | 8/13/2026 | View profile |
| Marshall Urist EVP, Research & Investments | ▼ Sell | Open Market | 0 Shares held | 10/5/2026 | View profile |
| Lloyd George W. EVP, Investments & GC | ▼ Sell | Open Market | 0 Shares held | 12/18/2025 | View profile |
Transaction History
| Marshall Urist | ▼ Sell | Open Market | 4,126 | $236K | 10/5/2026 |
| Bonnie L. Bassler | ▲ Buy | Grant | 642 | $37K | 9/30/2026 |
| Marshall Urist | ▼ Sell | Open Market | 4,126 | $239K | 9/28/2026 |
| Christopher Hite | ▼ Sell | Open Market | 96,073 | $5.6M | 9/22/2026 |
| Christopher Hite | ▼ Sell | Open Market | 3,927 | $231K | 9/22/2026 |
| Christopher Hite | ▼ Sell | Gift | 16,800 | $0 | 8/19/2026 |
| Christopher Hite | ▼ Sell | Open Market | 100,000 | $6.0M | 8/18/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 9,230 | $541K | 8/13/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 1,772 | $105K | 8/13/2026 |
| Pablo G. Legorreta | ▲ Buy | Grant | 65,216 | $0 | 8/5/2026 |
| Terrance P. Coyne | ▲ Buy | Grant | 11,002 | $0 | 8/5/2026 |
| Christopher Hite | ▲ Buy | Grant | 11,002 | $0 | 8/5/2026 |
| Marshall Urist | ▲ Buy | Grant | 8,252 | $0 | 8/5/2026 |
| Marshall Urist | ▼ Sell | Open Market | 9,099 | $508K | 7/1/2026 |
| Bonnie L. Bassler | ▲ Buy | Grant | 689 | $37K | 6/30/2026 |
| Christopher Hite | ▼ Sell | Open Market | 97,446 | $5.5M | 6/30/2026 |
| Christopher Hite | ▼ Sell | Open Market | 2,554 | $146K | 6/30/2026 |
| Christopher Hite | ▼ Sell | Open Market | 29,400 | $1.7M | 6/30/2026 |
| Christopher Hite | ▼ Sell | Open Market | 600 | $34K | 6/30/2026 |
| Marshall Urist | ▼ Sell | Open Market | 9,098 | $502K | 6/24/2026 |
| Christopher Hite | ▼ Sell | Open Market | 32,408 | $1.8M | 6/23/2026 |
| Christopher Hite | ▼ Sell | Open Market | 117,592 | $6.4M | 6/23/2026 |
| Elizabeth H. Weatherman | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| Gregory Norden | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| Ted W. Love | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| David C. Hodgson | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| Carole Ho | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| Catherine M. Engelbert | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| Vlad Coric | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| Bonnie L. Bassler | ▲ Buy | Grant | 4,545 | $0 | 6/5/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 64,399 | $3.5M | 5/26/2026 |
| Marshall Urist | ▼ Sell | Open Market | 13,684 | $722K | 5/20/2026 |
| Marshall Urist | ▼ Sell | Open Market | 13,684 | $726K | 5/14/2026 |
| Gregory Norden | ▼ Sell | Open Market | 3,045 | $161K | 5/14/2026 |
| Pablo G. Legorreta | ▲ Buy | Grant | 143,821 | $0 | 5/6/2026 |
| Terrance P. Coyne | ▲ Buy | Grant | 24,263 | $0 | 5/6/2026 |
| Christopher Hite | ▲ Buy | Grant | 24,263 | $0 | 5/6/2026 |
| Marshall Urist | ▲ Buy | Grant | 18,197 | $0 | 5/6/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 32,916 | $1.6M | 4/28/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 1,875 | $93K | 4/28/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 1,875 | $91K | 4/1/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 32,916 | $1.6M | 4/1/2026 |
| Bonnie L. Bassler | ▲ Buy | Grant | 815 | $37K | 3/31/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 32,916 | $1.5M | 3/23/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 1,875 | $85K | 3/23/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 22,487 | $1.0M | 3/2/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 10,429 | $490K | 3/2/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 1,292 | $60K | 3/2/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 583 | $27K | 3/2/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 1,875 | $85K | 2/23/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 32,916 | $1.5M | 2/23/2026 |
| Pablo G. Legorreta | ▲ Buy | Grant | 157,828 | $0 | 2/11/2026 |
| Terrance P. Coyne | ▲ Buy | Grant | 26,626 | $0 | 2/11/2026 |
| Christopher Hite | ▲ Buy | Grant | 26,626 | $0 | 2/11/2026 |
| Marshall Urist | ▲ Buy | Grant | 19,970 | $0 | 2/11/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 19,076 | $826K | 2/4/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 1,087 | $47K | 2/4/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 108,759 | $4.7M | 2/3/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 6,195 | $265K | 2/3/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 5,843 | $246K | 2/2/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 102,581 | $4.3M | 2/2/2026 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $822K | 1/30/2026 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $805K | 1/23/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 65,832 | $2.6M | 1/20/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 3,750 | $148K | 1/20/2026 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $790K | 1/16/2026 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $816K | 1/9/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 65,832 | $2.5M | 1/2/2026 |
| Terrance P. Coyne | ▼ Sell | Open Market | 3,750 | $144K | 1/2/2026 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $770K | 1/2/2026 |
| Bonnie L. Bassler | ▲ Buy | Grant | 967 | $37K | 12/31/2025 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $786K | 12/26/2025 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $768K | 12/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 30,654 | $1.2M | 12/18/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 79,346 | $3.1M | 12/17/2025 |
| Marshall Urist | ▼ Sell | Open Market | 20,000 | $766K | 12/16/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 65,832 | $2.5M | 12/15/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 3,750 | $144K | 12/15/2025 |
| Marshall Urist | ▼ Sell | Open Market | 18,242 | $714K | 12/5/2025 |
| Marshall Urist | ▼ Sell | Open Market | 23,334 | $914K | 12/5/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 110,000 | $4.4M | 12/3/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 65,832 | $2.6M | 12/1/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 3,750 | $149K | 12/1/2025 |
| Marshall Urist | ▼ Sell | Open Market | 23,333 | $932K | 12/1/2025 |
| Marshall Urist | ▼ Sell | Open Market | 18,242 | $728K | 12/1/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 55,146 | $2.1M | 11/24/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 10,686 | $406K | 11/24/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 3,126 | $121K | 11/24/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 624 | $24K | 11/24/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 47,798 | $1.8M | 11/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 4,628 | $181K | 11/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 47,401 | $1.8M | 11/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 4,599 | $179K | 11/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 25,530 | $977K | 11/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 2,470 | $96K | 11/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 2,770 | $106K | 11/19/2025 |
| Lloyd George W. | ▼ Sell | Open Market | 230 | $9K | 11/19/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 65,844 | $2.6M | 11/17/2025 |
| Terrance P. Coyne | ▼ Sell | Open Market | 3,750 | $147K | 11/17/2025 |
| Marshall Urist | ▼ Sell | Other | 160,000 | $0 | 11/7/2025 |
| Marshall Urist | ▲ Buy | Grant | 4,626 | $0 | 11/5/2025 |
| Christopher Hite | ▲ Buy | Grant | 6,168 | $0 | 11/5/2025 |
| Lloyd George W. | ▲ Buy | Grant | 6,168 | $0 | 11/5/2025 |
| Pablo G. Legorreta | ▲ Buy | Grant | 36,559 | $0 | 11/5/2025 |
| Terrance P. Coyne | ▲ Buy | Grant | 6,168 | $0 | 11/5/2025 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,047 | $37K | 9/30/2025 |
| Gregory Norden | ▼ Sell | Open Market | 33,500 | $1.2M | 8/11/2025 |
| Gregory Norden | ▼ Sell | Other | 144,660 | $0 | 8/8/2025 |
| Christopher Hite | ▲ Buy | Grant | 3,696 | $0 | 8/6/2025 |
| Lloyd George W. | ▲ Buy | Grant | 3,696 | $0 | 8/6/2025 |
| Marshall Urist | ▲ Buy | Grant | 2,772 | $0 | 8/6/2025 |
| Pablo G. Legorreta | ▲ Buy | Grant | 21,901 | $0 | 8/6/2025 |
| Terrance P. Coyne | ▲ Buy | Grant | 3,696 | $0 | 8/6/2025 |
| Carole Ho | ▲ Buy | Grant | 2,752 | $0 | 7/31/2025 |
| Elizabeth H. Weatherman | ▲ Buy | Grant | 5,806 | $0 | 7/31/2025 |
| Elizabeth H. Weatherman | ▲ Buy | Grant | 2,752 | $0 | 7/31/2025 |
| Carole Ho | ▲ Buy | Grant | 5,806 | $0 | 7/31/2025 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,064 | $37K | 6/30/2025 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,064 | $37K | 6/30/2025 |
| Pablo G. Legorreta | ▼ Sell | Other | 530,348 | $0 | 5/16/2025 |
| Gregory Norden | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| David C. Hodgson | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| Catherine M. Engelbert | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| Ted W. Love | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| Henry A. Fernandez | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| Errol B. Desouza | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| Vlad Coric | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| Bonnie L. Bassler | ▲ Buy | Grant | 7,614 | $0 | 5/13/2025 |
| Pablo G. Legorreta | ▲ Buy | Grant | 288,352 | $0 | 5/8/2025 |
| Lloyd George W. | ▲ Buy | Grant | 48,646 | $0 | 5/8/2025 |
| Christopher Hite | ▲ Buy | Grant | 48,646 | $0 | 5/8/2025 |
| Terrance P. Coyne | ▲ Buy | Grant | 48,646 | $0 | 5/8/2025 |
| Marshall Urist | ▲ Buy | Grant | 36,484 | $0 | 5/8/2025 |
| Vlad Coric | ▲ Buy | Grant | 3,184 | $0 | 4/21/2025 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,141 | $37K | 3/31/2025 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,141 | $37K | 3/31/2025 |
| Christopher Hite | ▼ Sell | Other | 300,000 | $0 | 2/14/2025 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,503 | $37K | 12/31/2024 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,503 | $37K | 12/31/2024 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,342 | $37K | 9/30/2024 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,342 | $37K | 9/30/2024 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,399 | $37K | 6/28/2024 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,399 | $37K | 6/28/2024 |
| Gregory Norden | ▲ Buy | Grant | 9,293 | $0 | 6/7/2024 |
| Ted W. Love | ▲ Buy | Grant | 9,293 | $0 | 6/7/2024 |
| David C. Hodgson | ▲ Buy | Grant | 9,293 | $0 | 6/7/2024 |
| Henry A. Fernandez | ▲ Buy | Grant | 9,293 | $0 | 6/7/2024 |
| Catherine M. Engelbert | ▲ Buy | Grant | 9,293 | $0 | 6/7/2024 |
| Errol B. Desouza | ▲ Buy | Grant | 9,293 | $0 | 6/7/2024 |
| Bonnie L. Bassler | ▲ Buy | Grant | 9,293 | $0 | 6/7/2024 |
| Christopher Hite | ▼ Sell | Other | 300,000 | $0 | 5/13/2024 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,240 | $37K | 3/28/2024 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,240 | $37K | 3/28/2024 |
| Rory B. Riggs | ▼ Sell | Other | 300,000 | $0 | 2/20/2024 |
| Rory B. Riggs | ▼ Sell | Open Market | 35,702 | $984K | 1/4/2024 |
| Rory B. Riggs | ▼ Sell | Open Market | 199,098 | $5.5M | 1/3/2024 |
| Rory B. Riggs | ▼ Sell | Open Market | 235,200 | $6.7M | 1/2/2024 |
| Avara Management Ltd | ▼ Sell | Open Market | 65,803 | $1.8M | 12/29/2023 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,353 | $37K | 12/29/2023 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,353 | $37K | 12/29/2023 |
| Avara Management Ltd | ▼ Sell | Open Market | 209,863 | $5.9M | 12/28/2023 |
| Avara Management Ltd | ▼ Sell | Open Market | 41,729 | $1.2M | 12/27/2023 |
| Avara Management Ltd | ▼ Sell | Open Market | 10,229 | $286K | 12/15/2023 |
| Avara Management Ltd | ▼ Sell | Open Market | 364,441 | $10.5M | 12/14/2023 |
| Avara Management Ltd | ▼ Sell | Open Market | 307,935 | $8.9M | 12/13/2023 |
| Pablo G. Legorreta | ▼ Sell | Other | 383,000 | $0 | 11/16/2023 |
| Lloyd George W. | ▼ Sell | Other | 50,000 | $0 | 11/13/2023 |
| Rory B. Riggs | ▼ Sell | Other | 475,590 | $0 | 11/13/2023 |
| Lloyd George W. | ▼ Sell | Other | 100,000 | $0 | 11/13/2023 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,384 | $37K | 9/29/2023 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,384 | $37K | 9/29/2023 |
| Terrance P. Coyne | ▼ Sell | Open Market | 37,500 | $1.2M | 8/10/2023 |
| Terrance P. Coyne | ▼ Sell | Open Market | 37,500 | $1.2M | 8/9/2023 |
| Terrance P. Coyne | ▼ Sell | Open Market | 37,500 | $1.2M | 7/13/2023 |
| Terrance P. Coyne | ▼ Sell | Open Market | 37,500 | $1.2M | 7/12/2023 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,208 | $37K | 6/30/2023 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,208 | $37K | 6/30/2023 |
| Pablo G. Legorreta | ▲ Buy | Open Market | 130,000 | $3.8M | 6/28/2023 |
| Ted W. Love | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| David C. Hodgson | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Gregory Norden | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Rory B. Riggs | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Giuliani Mario Germano | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Errol B. Desouza | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Bonnie L. Bassler | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Henry A. Fernandez | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Catherine M. Engelbert | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 |
| Pablo G. Legorreta | ▲ Buy | Open Market | 45,000 | $1.5M | 6/13/2023 |
| Pablo G. Legorreta | ▲ Buy | Open Market | 45,000 | $1.5M | 6/12/2023 |
| Lloyd George W. | ▼ Sell | Open Market | 79,099 | $2.7M | 6/6/2023 |
| Lloyd George W. | ▼ Sell | Open Market | 19,215 | $644K | 6/5/2023 |
| Lloyd George W. | ▼ Sell | Open Market | 1,686 | $57K | 6/2/2023 |
| Lloyd George W. | ▼ Sell | Open Market | 92,221 | $3.1M | 6/2/2023 |
| Pablo G. Legorreta | ▲ Buy | Open Market | 150,000 | $4.8M | 5/24/2023 |
| Rory B. Riggs | ▼ Sell | Open Market | 1,750,000 | $57.4M | 5/22/2023 |
| Pablo G. Legorreta | ▲ Buy | Open Market | 69,612 | $2.3M | 5/17/2023 |
| Pablo G. Legorreta | ▲ Buy | Open Market | 160,388 | $5.4M | 5/16/2023 |
| Rory B. Riggs | ▼ Sell | Other | 300,000 | $0 | 5/9/2023 |
| Bonnie L. Bassler | ▲ Buy | Grant | 1,049 | $37K | 3/31/2023 |
| Henry A. Fernandez | ▲ Buy | Grant | 1,049 | $37K | 3/31/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Royalty Pharma Declares Q4 2026 Dividend
Royalty Pharma announced its fourth-quarter 2026 dividend, a routine move that supports its status as a consistent income provider with a yield near 3%. Recent commentary also highlights the company's valuation metrics, noting that its multiples may offer an attractive risk-reward balance for some market participants. The stock currently trades within its 52-week range, with analysts maintaining a consensus target price above current levels.
Royalty Pharma Declares Q4 2026 Dividend. Royalty Pharma announced its fourth-quarter 2026 dividend, a routine move that supports its status as a consistent income provider with a yield near 3%. Recent commentary also highlights the company's valuation metrics, noting that its multiples may offer an attractive risk-reward balance for some market participants. The stock currently trades within its 52-week range, with analysts maintaining a consensus target price above current levels.